Benzinga's Top Upgrades
Analysts at Wells Fargo upgraded Allergan (NYSE: AGN) from “market perform” to “outperform.” The target price range for Allergan has been raised from $99-$100 to $121-$122. Allergan's shares closed at $107.39 yesterday.
CRT Capital upgraded Engility Holdings (NYSE: EGL) from “fairly valued” to “buy.” The target price for Engility Holdings is set to $40. Engility Holdings' shares closed at $32.14 yesterday.
Analysts at Wells Fargo upgraded Eagle Rock Energy Partners LP (NASDAQ: EROC) from “market perform” to “outperform.” Eagle Rock Energy Partners' shares closed at $5.92 yesterday.
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.